Confronting Inequities: MS & the Black Experience

CME/CE

Jointly provided by Partners for Advancing Clinical Education (PACE) and DKBmed, LLC. 

Acknowledgement

This activity is supported by an independent educational grant from Sanofi and Genentech, a member of the Roche Group. 

Target Audience

This activity is intended for physicians, physician assistants and associates, registered nurses, and nurse practitioners who care for patients from ethnic and racial minorities groups that experience differences in MS-related morbidity and mortality. 

Educational Objectives

Upon completion of this activity, participants should be able to: 

  • Describe variations in MS disease course based on race/ethnicity.  
  • Discuss interventions that may alleviate disparities and inequities in access to care for people with MS from ethnic/racial groups.  
  • Explain the modifiable patient-related factors that contribute to diverse health outcomes in patients with MS.  

Faculty and Disclosure of Conflicts of Interest

FacultyConflicts of Interest
Diana Andino, MD
Neurologist, Andrew C. Carlos Multiple
Sclerosis Institute 		Consultant, Advisor, Speaker: Genentech
Consultant, Advisor, Speaker: EMD Serono
Consultant, Advisor, Speaker: Multiple Sclerosis American Association
Annette Okai, MD
Neurologist, Austin Regional Clinic 		Consultant, Advisor, Speaker: Genentech
Consultant, Advisor, Speaker: EMD Serono
Consultant, Advisor, Speaker: Sanofi Genzyme
Consultant, Advisor, Speaker: Bristol Myers Squibb
Consultant, Advisor, Speaker: Biogen
Researcher: TG Therapeutics
Jaqueline Rosenthal, MD
Director, Neuroimmunology & Multiple Sclerosis Research 		Consultant, Advisor, Speaker: Genentech
Consultant, Advisor, Speaker: EMD Serono
Consultant, Advisor, Speaker: Horizon
Consultant, Advisor, Speaker: Alexion
Consultant, Advisor, Speaker: TG Therapeutics
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not the specific proprietary business interest of an ineligible company.

Faculty / Presenter Reported Financial Relationship

The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The DKBmed planners and others have no relevant financial relationship(s) to disclose with ineligible companies. 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and DKBmed LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hours.

PA Continuing Medical Education

PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until November 2024. PAs should only claim credit commensurate with the extent of their participation.


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

There are no fees for participating and receiving CME/CE credit for this activity. 

Request for Credit

If you wish to receive acknowledgment for completing this activity, please complete the evaluation. 

  • Release date: 10/18/2023 
  • Expiration date: November 2024 

Estimated time to complete the activity: 1 Hour 

Hardware & Software Requirements

To access activities, users will need:  

  • A computer with an internet connection  
  • An HTML5 compliant web browser or Internet Explorer 8 (and higher)  

Contact Information

For additional information about the accreditation of this activity, please visit https://partnersed.com